Scientific letter

DOI: 10.1016/j.gastrohep.2022.02.008

A high adalimumab induction dosing regimen achieves clinical and endoscopic remission in super-refractory ulcerative colitis

Una pauta de inducción con dosis altas de adalimumab consigue la remisión clínica y endoscópica en colitis ulcerosa superrefractaria

Visits

314

Download PDF

Alexandra Ruiz-Cerulla

Corresponding author

aruizcerulla@bellvitgehospital.cat

Corresponding author.

, Lorena Rodríguez-Alonso, Francisco Rodríguez-Moranta, Jordi Guardiola

Department of Gastroenterology, Hospital Universitari de Bellvitge-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain